FdaApplication

BLA 125585

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBloodworks
application_typeBLA
approval_date2016-01-28

Products (1)

ProductActive ingredientStrengthDosage form
HPC, CORD BLOOD—5X10^8 NUCLEATED CELLS CONTENT WITH 85% VIABILITY & 1.25X10^6 VIABLE CD34+ CELLS (PRE-CRYOPRESERVATION)Injection

1 product